Evidence map›Paper›PMID 40380154›Full record

ArticleBMC medical informatics and decision making2025

Federated SPARQL query performance evaluation for exploring disease model mouse: combining gene expression, orthology, and disease knowledge graphs.

Tatsuya Kushida, Tarcisio Mendes de Farias, Ana C Sima, Christophe Dessimoz, Hirokazu Chiba, Frederic B Bastian, Hiroshi Masuya

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tatsuya KushidaBioResource Research Center, RIKEN, Tsukuba-shi, Japan. tatsuya.kushida@riken.jp.ORCID 0000-0002-0784-4113
Tarcisio Mendes de FariasSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0002-3175-5372
Ana C SimaSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0003-3213-4495
Christophe DessimozSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0002-2170-853X
Hirokazu ChibaDatabase Center for Life Science, DS, ROIS, Kashiwa-shi, Japan.ORCID 0000-0003-4062-8903
Frederic B BastianSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0002-9415-5104
Hiroshi MasuyaBioResource Research Center, RIKEN, Tsukuba-shi, Japan.ORCID 0000-0002-3392-466X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe RIKEN BRC develops and maintains the RIKEN BioResource MetaDatabase to help users explore appropriate target bioresources for their experiments and prepare precise and high-quality data infrastructures. The Swiss Institute of Bioinformatics develops two databases across multi-species for the study of gene expression and orthology: Bgee and Orthologous MAtrix (OMA, an orthology database).

methodsThis study combines the RIKEN BioResource data with Resource Description Framework (RDF) datasets from Bgee, a gene expression database, the OMA, the DisGeNET, a human gene-disease association, Mouse Genome Informatics (MGI), UniProt, and four disease ontologies in the RIKEN BioResource MetaDatabase. Our aim is to evaluate the distributed SPARQL query performance when exploring which model organisms are most appropriate for specific medical science research applications across the aforementioned interoperable datasets. More precisely in our biomedical use cases, we investigate disease-related genes, as well as anatomical parts where these genes are expressed and subsequently identify appropriate bioresource candidates available for specific disease research applications.

resultsWe illustrate the above through two use cases targeting either Alzheimer's disease or melanoma. We identified 14 Alzheimer's disease-related genes that were expressed in the prefrontal cortex (e.g., APP and APOE) and 55 RIKEN bioresources, which were genetically modified mice related to these genes, predicted to be relevant to Alzheimer's disease research. Furthermore, executing a transitive search for the Uberon terms by using the Property Paths function, we identified 14 melanoma-related genes (e.g., HRAS and PTEN), and 12 anatomical parts in which these genes were expressed, such as the "skin of limb" as an example. Finally, we compared the performance of the federated SPARQL query via the remote Bgee SPARQL endpoint with the performance of a centralized SPARQL query using the Bgee dataset as part of the RIKEN BioResource MetaDatabase.

conclusionsAs a result, we confirmed that the performance of the federated approach degraded. We concluded that we reduced the degradation of the query performance of the federated approach from the BioResource MetaDatabase to the SIB by refining the transferred data through a subquery and enhancing the server specifications thereby optimizing the triple store query evaluation.

Indexed as

Computational BiologyDatabases, GeneticDisease Models, AnimalGene ExpressionAnimalsHumansMiceDatabase integrationGene-disease associationGene expressionKnowledge graphModel organismOntologyOrthologyRDFSPARQL

Identifiers

PMID40380154
PMCPMC12082848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.